Latest News about RYTM
Recent news which mentions RYTM
Rhythm Pharma Shares Fall After Modifications To Setmelanotide Trials In Rare Diseases of Obesity
April 06, 2022
Tickers
RYTM
From Benzinga
Earnings Scheduled For March 1, 2022
March 01, 2022
From Benzinga
From Benzinga
60 Biggest Movers From Yesterday
February 18, 2022
From Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
February 17, 2022
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For February 17, 2022
February 17, 2022
From Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
February 17, 2022
From Benzinga
Rhythm Pharma's Highlights Interim Setmelanotide Data In Long Term Genetic Disorder Trial
February 16, 2022
Tickers
RYTM
From Benzinga
Stocks That Hit 52-Week Lows On Monday
February 14, 2022
From Benzinga
52 Weeks High And Low Article
February 11, 2022
From Benzinga
Stocks That Hit 52-Week Lows On Friday
February 04, 2022
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 8, 2021
December 08, 2021
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 19, 2021
November 19, 2021
From Benzinga
Earnings Scheduled For November 2, 2021
November 02, 2021
From Benzinga
The Daily Biotech Pulse: NRx Stitches COVID-19 Drug Partnership, Protara Gets Nod For Starting Bladder Cancer Study, IGM Moves Beyond Oncology
October 12, 2021
From Benzinga
Rhythm Pharma's Imcivree Wins UK Approval For Obesity, Hunger Control
September 22, 2021
Tickers
RYTM
From Benzinga
The Daily Biotech Pulse: ProQR-Lilly R&D Partnership, Sanofi's Pemphigus Trial Disappointment, Humanigen's COVID-19 Drug Denied Emergency Use Authorization
September 09, 2021
From Benzinga
Stocks That Hit 52-Week Lows On Friday
August 20, 2021
From Benzinga
The Daily Biotech Pulse: J&J Announces CEO Transition, FibroGen's Roxadustat Approved In Europe, GeoVax, Sorrento Announce COVID-19 Vaccine Data
August 20, 2021
From Benzinga
Stocks That Hit 52-Week Lows On Thursday
August 19, 2021
From Benzinga
From Benzinga
Stocks That Hit 52-Week Lows On Tuesday
August 17, 2021
From Benzinga
From Benzinga
The Daily Biotech Pulse: Dicerna Slips On Data, Novavax Tightlipped On US Vaccine Approval, Adagio IPO
August 06, 2021
From Benzinga
Stocks That Hit 52-Week Lows On Thursday
August 05, 2021
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.